摘要
糖尿病黄斑水肿(DME)的发病率正逐渐上升,其作为导致糖尿病患者视力不可逆丧失的主要原因,一直受到医学研究者的关注。目前,在应用诸如光学相干断层扫描和抗血管内皮生长因子等针对DME的诊疗方法的同时,多种新兴的解决方案正在被研发。因此,本文将对现有DME的诊断和治疗方案进行总结讨论,以期为未来DME诊疗标准的统一奠定基础。
The incidence rate of diabetic macular edema(DME)is rising.As the main cause for irreversible loss of vision in diabetic patients,DME has been getting more attention of medical researchers.In addition to existing optical coherence tomography and anti-vascular endothelial growth factor therapies for DME,a variety of new solutions are being developed.This article summarizes and discusses current diagnostic and therapeutic methods for DME,laying a foundation for its unified diagnosis and treatment in the future.
作者
邵毅
李乐妍
魏红
SHAO Yi;LI Leyan;WEI Hong(Department of Ophthalmology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi Province,China)
出处
《眼科新进展》
CAS
北大核心
2022年第11期841-846,共6页
Recent Advances in Ophthalmology
基金
中央引导地方科技发展基金(编号:20211ZDG02003)
江西省重点研发项目(编号:20181BBG70004,20203BBG73059)。
